Ochratoxin a: Molecular interactions, mechanisms of toxicity and prevention at the molecular level

Toxins

Volumn 8, Issue 4, 2016, Pages

  Kőszegi, Tamás ^a   Poór, Miklós ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Albumin binding; Cellular effects; Flavonoids; Nephropathy; Ochratoxin A; Prevention; Toxicokinetics

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 25; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OCHRATOXIN; UNCLASSIFIED DRUG; ALBUMINOID; PROTECTIVE AGENT;

APOPTOSIS; BIOTRANSFORMATION; BREAST MILK; CELL CYCLE ARREST; ENERGY YIELD; FECES; GENOTOXICITY; HUMAN; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN SYNTHESIS; REVIEW; TISSUE DISTRIBUTION; TOXICOKINETICS; URINARY EXCRETION; ANIMAL; CHEMISTRY; DIET; FOOD CONTAMINATION; METABOLISM;

ALBUMINS; ANIMALS; DIET; FOOD CONTAMINATION; HUMANS; OCHRATOXINS; PROTECTIVE AGENTS;

EID: 84964285128     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins8040111     Document Type: Review

References (266)

1. Ringot, D., Chango, A., Schneider, Y.J., Larondelle, Y. Toxicokinetics and toxicodynamics of Ochratoxin A, an update. Chem. Biol. Interact. 2006, 159, 18-46. [CrossRef] [PubMed]
2. Van Der Merwe, K.J., Steyn, P.S., Fourie, L. Part II. The constitution of Ochratoxins A, B, and C, metabolites of Aspergillus ochraceus wilh. J. Chem. Soc. 1965, 7083-7088. [CrossRef]
3. Pohland, A.E., Nesheim, S., Friedman, L. Ochratoxin A: A review. Pure Appl. Chem. 1992, 64, 1029-1046. [CrossRef]
4. Speijers, G.J.A., van Egmond, H. P. Worldwide Ochratoxin A levels in food and feeds. In Human Ochratoxicosis and its Pathologies; Creppy, E.E., Castegnaro, M., Dirheimer, G., Eds., John Libbey Eurotext: London, UK, 1993; Vol. 231, pp. 85-100.
5. Krogh, P., Hald, B., Plestina, R., Ceović, S. Balkan (endemic) nephropathy and foodborn Ochratoxin A: Preliminary results of a survey of foodstuffs. Acta Pathol. Microbiol. Scand. B 1977, 85, 238-240. [CrossRef] [PubMed]
6. Pavlovic, M., Plestina, R., Krogh, P. Ochratoxin A contamination of foodstuffs in an area with Balkan (endemic) nephropathy. Acta Pathol. Microbiol. Scand. B 1979, 87, 243-246. [CrossRef] [PubMed]
7. Petkova-Bocharova, T., Castegnaro, M. Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria. Food Addit. Contam. 1985, 2, 267-270. [CrossRef] [PubMed]
8. Petkova-Bocharova, T., Castegnaro, M., Michelon, J., Maru, V. Ochratoxin A and other mycotoxins in cereals from an area of Balkan endemic nephropathy and urinary tract tumours in Bulgaria. In Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours; Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I.N., Bartsch, H., Eds., IARC Scientific Publications: Lyon, France, 1991; pp. 83-87.
9. Pfohl-Leszkowicz, A., Petkova-Bocharova, T., Chernozemsky, I.N., Castegnaro, M. Balkan endemic nephropathy and associated urinary tract tumours: A review on aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 2002, 19, 282-302. [CrossRef] [PubMed]
10. Vrabcheva, T., Usleber, E., Dietrich, R., Martlbauer, E. Co-occurrence of Ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J. Agric. Food Chem. 2000, 48, 2483-2488. [CrossRef] [PubMed]
11. Bui-Klimke, T., Wu, F. Evaluating weight of evidence in the mystery of balkan endemic nephropathy. Risk Anal. 2014, 34, 1688-1705. [CrossRef] [PubMed]
12. Pavlović, N.M. Balkan endemic nephropathy—Current status and future perspectives. Clin. Kidney J. 2013, 6, 257-265. [CrossRef] [PubMed]
13. Markovic, B., Lebedev, S., Djordjevic, M., Arambasic, M. Endemic urinary tract cancer in Bulgaria, Yugoslavia and Romania: Etiology and pathogenesis. Med. Biol. Environ. 1976, 1-2.
14. Chernozemsky, I.N., Stoyanov, I.S., Petkova-Bocharova, T.K., Nicolov, I.G., Draganov, I.V., Stoichev, I.I., Tanchev, Y., Naidenov, D., Kalcheva, N.D. Geographic correlation between the occurrence of endemic nephropathy and urinary tract tumours in vratza district, Bulgaria. Int. J. Cancer 1977, 19, 1-11. [CrossRef] [PubMed]
15. Pfohl-Leszkowicz, A. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh. Hig. Rada Toksikol. 2009, 60, 465-483. [CrossRef] [PubMed]
16. Duarte, S.C., Pena, A., Lino, C.M. Ochratoxin A non-conventional exposure sources—A review. Microchem. J. 2009, 93, 115-120. [CrossRef]
17. Amézqueta, S., González-Peñas, E., Murillo-Arbizu, M., López de Cerain, A. Ochratoxin A decontamination: A review. Food Control 2009, 20, 326-333. [CrossRef]
18. Ciconová, P., Laciková, A., Máté, D. Prevention of Ochratoxin A contamination of food and Ochratoxin A detoxification by microorganisms—A review. Czech J. Food Sci. 2010, 28, 465-474.
19. Pfohl-Leszkowicz, A., Hadjeba-Medjdoub, K., Ballet, N., Schrickx, J., Fink-Gremmels, J. Assessment and characterization of yeast-based products intended to mitigate ochratoxin exposure using in vitro and in vivo models. Food Addit. Contam. A 2015, 32, 604-616. [CrossRef] [PubMed]
20. Radic, B., Fuchs, R., Peraica, M., Lucic, A. Ochratloxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol. Lett. 1997, 91, 105-109. [CrossRef]
21. Peraica, M., Domijan, A.M., Fuchs, R., Lucic, A., Radic, B. The occurrence of Ochratoxin A in blood in general population of Croatia. Toxicol. Lett. 1999, 110, 105-112. [CrossRef]
22. Özcelik, N., Kosar, A., Soysal, D. Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders. Toxicol. Lett. 2001, 121, 9-13. [CrossRef]
23. Lino, C.M., Baeta, M.L., Henri, M., Dinis, A.M.P., Pena, A.S., Silveira, M.I.N. Levels of Ochratoxin A in serum from urban and rural Portuguese populations and estimation of exposure degree. Food Chem. Toxicol. 2008, 46, 879-885. [CrossRef] [PubMed]
24. Perry, J.L., Christensen, T., Goldsmith, M.R., Toone, E.J., Beratan, D.N., Simon, J.D. Binding of Ochratoxin A to human serum albumin stabilized by a protein-ligand ion pair. J. Phys. Chem. B 2003, 107, 7884-7888. [CrossRef]
25. Poór, M., Kunsági-Máté, S., Bencsik, T., Petrik, J., Vladimir-Knežević, S., Kőszegi, T. Flavonoid aglycones can compete with Ochratoxin A for human serum albumin: A new possible mode of action. Int. J. Biol. Macromol. 2012, 51, 279-283. [CrossRef] [PubMed]
26. Poór, M., Kunsági-Máté, S., Matisz, G., Li, Y., Czibulya, Z., Peles-Lemli, B., Kőszegi, T. Interaction of alkali and alkaline earth ions with Ochratoxin A. J. Lumin. 2013, 135, 276-280.
27. Hagelberg, S., Hult, K., Fuchs, R. Toxicokinetics of Ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 1989, 9, 91-96. [CrossRef] [PubMed]
28. Studer-Rohr, I., Schlatter, J., Dietrich, D.R. Kinetic parameters and intraindividual fluctuations of Ochratoxin A plasma levels in human. Arch. Toxicol. 2000, 74, 499-510. [CrossRef] [PubMed]
29. Kumagai, S. Ochratoxin A: Plasma concentration and excretion into bile and urine in albumin-deficient rats. Food Chem. Toxicol. 1985, 23, 941-943. [CrossRef]
30. Poór, M., Kunsági-Máté, S., Czibulya, Z., Li, Y., Peles-Lemli, B., Petrik, J., Vladimir-Knežević, S., Kőszegi, T. Fluorescence spectroscopic investigation of competitive interactions between Ochratoxin A and 13 drug molecules for binding to human serum albumin. Luminescence 2013, 28, 726-733. [CrossRef] [PubMed]
31. Poór, M., Li, Y., Matisz, G., Kiss, L., Kunsági-Máté, S., Kőszegi, T. Quantitation of species differences in albumin-ligand interactions for bovine, human and rat serum albumins using fluorescence spectroscopy: A test case with some Sudlow’s site I ligands. J. Lumin. 2014, 145, 767-773.
32. Li, Y., Czibulya, Z., Poór, M., Lecomte, S., Kiss, L., Harte, E., Kőszegi, T., Kunsági-Máté, S. Thermodynamic study of the effects of ethanol on the interaction of Ochratoxin A with human serum albumin. J. Lumin. 2014, 148, 18-25. [CrossRef]
33. Castegnaro, M., Canadas, D., Vrabcheva, T., Petkova-Bocharova, T., Chernozemsky, I.N., Pfohl-Leszkowicz, A. Balkan endemic nephropathy: Role of Ochratoxins A through biomarkers. Mol. Nutr. Food Res. 2006, 50, 519-529. [CrossRef] [PubMed]
34. Pfohl-Leszkowicz, A., Manderville, R.A. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51, 61-99. [CrossRef] [PubMed]
35. Manderville, R.A. A case for the genotoxicity of Ochratoxin A by bioactivation and covalent DNA adduction. Chem. Res. Toxicol. 2005, 18, 1091-1097. [CrossRef] [PubMed]
36. Turesky, R.J. Perspective: Ochratoxin A is not a genotoxic carcinogen. Chem. Res. Toxicol. 2005, 18, 1082-1090. [CrossRef] [PubMed]
37. Manderville, R., Pfohl-Leszkowicz, A. Bioactivation and DNA adduction as a rationale for Ochratoxin A carcinogenesis. World Mycotoxin J. 2008, 1, 357-367. [CrossRef]
38. Pfohl-Leszkowicz, A., Manderville, R.A. An update on direct genotoxicity as a molecular mechanism of Ochratoxin A carcinogenicity. Chem. Res. Toxicol. 2012, 25, 252-262. [CrossRef] [PubMed]
39. Hadjeba-Medjdoub, K., Tozlovanu, M., Pfohl-Leszkowicz, A., Frenette, C., Paugh, R.J., Manderville, R.A. Structure-activity relationships imply different mechanisms of action for Ochratoxin A-mediated cytotoxicity and genotoxicity. Chem. Res. Toxicol. 2012, 25, 181-190. [CrossRef] [PubMed]
40. El Khoury, A., Atoui, A. Ochratoxin A: General overview and actual molecular status. Toxins 2010, 2, 461-493. [CrossRef] [PubMed]
41. IARC. Ochratoxin A. Monographs on the Evaluation of Carcinogenic Risks to Humans. In Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins; International Agency for Research on Cancer: Lyon, France, 1993; pp. 489-521.
42. Boorman, G. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies); NIH Publication No. 89-2813; U.S. Department of Health and Human Services, National Institutes of Health: Research Triangle Park, NC, USA, 1989.
43. Chernozemsky, I.N. Balkan endemic nephropathy and the associated tumours of the urinary system: A summary of epidemiological features in Bulgaria. IARC Sci. Publ. 1991, 115, 3-4. [PubMed]
44. Hassen, W., Abid-Essafi, S., Achour, A., Guezzah, N., Zakhama, A., Ellouz, F., Creppy, E.E., Bacha, H. Karyomegaly of tubular kidney cells in human chronic interstitial nephropathy in Tunisia: Respective role of Ochratoxin A and possible genetic predisposition. Hum. Exp. Toxicol. 2004, 23, 339-346. [CrossRef] [PubMed]
45. Cui, J., Xing, L., Li, Z., Wu, S., Wang, J., Liu, J., Wang, J., Yan, X., Zhang, X. Ochratoxin A induces G(2) phase arrest in human gastric epithelium GES-1 cells in vitro. Toxicol. Lett. 2010, 193, 152-158. [CrossRef] [PubMed]
46. Liu, J., Wu, S., Shen, H., Cui, J., Wang, Y., Xing, L., Wang, J., Yan, X., Zhang, X. Ochratoxin A induces DNA damage and G2 phase arrest in human esophageal epithelium Het-1A cells in vitro. J. Toxicol. Sci. 2015, 40, 657-665. [CrossRef] [PubMed]
47. Schwartz, G.G. Hypothesis: Does Ochratoxin A cause testicular cancer? Cancer Causes Control 2002, 13, 91-100. [CrossRef] [PubMed]
48. Pohland, A.E., Schuller, P.L., Steyn, P.S. Physicochemical data for some selected mycotoxins. Pure Appl. Chem. 1982, 54, 2219-2284. [CrossRef]
49. Vidal, A., Sanchis, V., Ramos, A.J., Marín, S. Thermal stability and kinetics of degradation of deoxynivalenol, deoxynivalenol conjugates and Ochratoxin A during baking of wheat bakery products. Food Chem. 2015, 178, 276-286. [CrossRef] [PubMed]
50. Trivedi, A.B., Doi, E., Kitabatake, N. Detoxification of Ochratoxin A on heating under acidic and alkaline conditions. Biosci. Biotech. Biochem. 1992, 56, 741-745. [CrossRef]
51. Boudra, H., Le Bars, P., Le Bars, J. Thermostability of Ochratoxin A in wheat under two moisture conditions. Appl. Environ. Microbiol. 1995, 61, 1156-1158. [PubMed]
52. Blanc, M., Pittet, A., Munoz-Box, R., Viani, R. Behavior of Ochratoxin A during green coffee roasting and soluble coffee manufacture. J. Agric. Food Chem. 1998, 46, 673-675. [CrossRef] [PubMed]
53. Van der Stegen, G.H., Essens, P.J., van der Lijn, J. Effect of roasting conditions on reduction of Ochratoxin A in coffee. J. Agric. Food Chem. 2001, 49, 4713-4715. [CrossRef] [PubMed]
54. Cramer, B., Königs, M., Humpf, H.U. Identification and in vitro cytotoxicity of Ochratoxin A degradation products formed during coffee roasting. J. Agric. Food Chem. 2008, 56, 5673-5681. [CrossRef] [PubMed]
55. Bellver Soto, J., Fernández-Franzón, M., Ruiz, M.J., Juan-García, A. Presence of Ochratoxin A (OTA) mycotoxin in alcoholic drinks from southern European countries: Wine and beer. J. Agric. Food Chem. 2014, 62, 7643-7651. [CrossRef] [PubMed]
56. Malir, F., Ostry, V., Pfohl-Leszkowicz, A., Toman, J., Bazin, I., Roubal, T. Transfer of Ochratoxin A into tea and coffee beverages. Toxins 2014, 6, 3438-3453. [CrossRef] [PubMed]
57. Flores-Flores, M.E., Lizarraga, E., López de Cerain, A., González-Penas, E. Presence of mycotoxins in animal milk: A review. Food Control 2015, 53, 163-176. [CrossRef]
58. Shim, W.B., Ha, K.S., Kim, M.G., Kim, J.S., Chung, D.H. Evaluation of the transfer rate of Ochratoxin A to decoctions of herbal medicines. Food Sci. Biotechnol. 2014, 23, 2103-2108. [CrossRef]
59. Chen, A.J., Jiao, X., Hu, Y., Lu, X., Gao, W. Mycobiota and Mycotoxins in traditional medicinal seeds from China. Toxins 2015, 7, 3858-3875. [CrossRef] [PubMed]
60. Veprikova, Z., Zachariasova, M., Dzuman, Z., Zachariasova, A., Fenclova, M., Slavikova, P., Vaclavikova, M., Mastovska, K., Hengst, D., Hajslova, J. Mycotoxins in plant-based dietary supplements: Hidden health risk for consumers. J. Agric. Food Chem. 2015, 63, 6633-6643. [CrossRef] [PubMed]
61. Solfrizzo, M., Piemontese, L., Gambacorta, L., Zivoli, R., Longobardi, F. Food coloring agents and plant food supplements derived from Vitis vinifera: A new source of human exposure to Ochratoxin A. J. Agric. Food Chem. 2015, 63, 3609-3614. [CrossRef] [PubMed]
62. Ostry, V., Malir, F., Ruprich, J. Producers and important dietary sources of Ochratoxin A and citrinin. Toxins 2013, 5, 1574-1586. [CrossRef] [PubMed]
63. Jeswal, P., Kumar, D. Mycobiota and natural incidence of Aflatoxins, Ochratoxin A, and Citrinin in Indian spices confirmed by LC-MS/MS. Int. J. Microbiol. 2015, 2015, 242-486. [CrossRef] [PubMed]
64. Do, K.H., An, T.J., Oh, S.K., Moon, Y. Nation-based occurrence and endogenous biological reduction of mycotoxins in medicinal herbs and spices. Toxins 2015, 7, 4111-4130. [CrossRef] [PubMed]
65. Mata, A.T., Ferreira, J.P., Oliveira, B.R., Batoréu, M.C., Barreto Crespo, M.T., Pereira, V.J., Bronze, M.R. Bottled water: Analysis of mycotoxins by LC-MS/MS. Food Chem. 2015, 176, 455-464. [CrossRef] [PubMed]
66. Galtier, P., Alvinerie, M., Charpenteau, J.L. The pharmacokinetic profiles of Ochratoxin A in pigs, rabbits and chickens. Food Cosmet. Toxicol. 1981, 19, 735-738. [CrossRef]
67. Galtier, P. Contribution of pharmacokinetic studies to mycotoxicology-Ochratoxin A. Vet. Sci. Commun. 1978, 1, 349-358. [CrossRef]
68. Kumagai, S., Aibara, K. Intestinal absorption and secretion of Ochratoxin A in the rat. Toxicol. Appl. Pharmacol. 1982, 64, 94-102. [CrossRef]
69. Roth, A., Chakor, K., Creppy, E.E., Kane, A., Roschenthaler, R., Dirheimer, G. Evidence for an enterohepatic circulation of Ochratoxin A in mice. Toxicology 1988, 48, 293-308. [CrossRef]
70. Berger, V., Gabriel, A.F., Sergent, T., Trouet, A., Larondelle, Y., Schneider, Y.J. Interaction of Ochratoxin A with human intestinal Caco-2 cells: Possible implication of a multidrug resistance-associated protein (MRP2). Toxicol. Lett. 2003, 140 141, 465-476. [CrossRef]
71. Schrickx, J., Lektarau, Y., Fink-Gremmels, J. Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Arch. Toxicol. 2006, 80, 243-249. [CrossRef] [PubMed]
72. Maresca, M., Mahfoud, R., Pfohl-Leszkowicz, A., Fantini, J. The mycotoxin Ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. Toxicol. Appl. Pharmacol. 2001, 176, 54-63. [CrossRef] [PubMed]
73. Il’ichev, Y.V., Perry, J.L., Simon, J.D. Interaction of Ochratoxin A with human serum albumin. Preferential binding of the dianion and pH effects. J. Phys. Chem. B 2002, 106, 452-459. [CrossRef]
74. Il’ichev, Y.V., Perry, J.L., Rüker, F., Dockal, M., Simon, J.D. Interaction of Ochratoxin A with human serum albumin. Binding sites localized by competitive interactions with the native protein and its recombinant fragments. Chem. Biol. Interact. 2002, 141, 275-293. [CrossRef]
75. Perry, J.L., Goldsmith, M.R., Peterson, M.A., Beratan, D.N. Structure of the Ochratoxin A binding site within human serum albumin. J. Phys. Chem. B 2004, 108, 16960-16964. [CrossRef]
76. Dai, J., Park, G., Perry, J.L., Il’ichev, Y.V., Bow, D.A., Pritchard, J.B., Faucet, V., Pfohl-Leszkowicz, A., Manderville, R.A., Simon, J.D. Molecular aspects of the transport and toxicity of Ochratoxin A. Acc. Chem. Res. 2004, 37, 874-881. [CrossRef] [PubMed]
77. Il’ichev, Y.V., Perry, J.L., Simon, J.D. Interaction of Ochratoxin A with human serum albumin. A common binding site of Ochratoxin A and warfarin in subdomain IIA. J. Phys. Chem. B 2002, 106, 460-465. [CrossRef]
78. Stojković, R., Hult, K., Gamulin, S., Plestina, R. High affinity binding of Ochratoxin A to plasma constituents. Biochem. Int. 1984, 9, 33-38. [PubMed]
79. Schwerdt, G., Freudinger, R., Silbernagl, S., Gekle, M. Ochratoxin A—binding proteins in rat organs and plasma and in different cell lines of the kidney. Toxicology 1999, 135, 1-10. [CrossRef]
80. Belmadani, A., Tramu, G., Betbeder, A.M., Steyn, P.S., Creppy, E.E. Regional selectivity to Ochratoxin A, distribution and cytotoxicity in rat brain. Arch. Toxicol. 1998, 72, 656-662. [CrossRef] [PubMed]
81. Jung, K.Y., Takeda, M., Kim, D.K., Tojo, A., Narikawa, S., Yoo, B.S., Hosoyamada, M., Cha, S.H., Sekine, T., Endou, H. Characterization of Ochratoxin A transport by human organic anion transporters. Life Sci. 2001, 69, 2123-2135. [CrossRef]
82. Kontaxi, M., Echkardt, U., Hagenbuch, B., Stieger, B., Meier, P.J., Petzinger, E. Uptake of the mycotoxin Ochratoxin A in liver cells occurs via the cloned organic anion transporting polypeptide. J. Pharmacol. Exp. Ther. 1996, 279, 1507-1513. [PubMed]
83. Anzai, N., Jutabha, P., Endou, H. Molecular mechanism of Ochratoxin A transport in the kidney. Toxins 2010, 2, 1381-1398. [CrossRef] [PubMed]
84. Takeuchi, A., Masuda, S., Saito, H., Abe, T., Inui, K. Multispecific substrate recognition of kidney-specific organic anion transporters OAT-K1 and OAT-K2. J. Pharmacol. Exp. Ther. 2001, 299, 261-267. [PubMed]
85. Zlender, V., Breljak, D., Ljubojević, M., Flajs, D., Balen, D., Brzica, H., Domijan, A.M., Peraica, M., Fuchs, R., Anzai, N., et al. Low doses of Ochratoxin A upregulate the protein expression of organic anion transporters Oat1, Oat2, Oat3 and Oat5 in rat kidney cortex. Toxicol. Appl. Pharmacol. 2009, 239, 284-296. [CrossRef] [PubMed]
86. Miraglia, M., Brera, C., Corneli, S., Cava, E., Montanino, G., Miraglia, E. Occurence of Ochratoxin A (OTA) in Maternal Serum, Placenta and Funiculum. In Proceedings of the IX International IUPAC Symposium on Mycotoxins and Phycotoxins—Developments in Chemistry, Toxicology and Food Safety, Rome, Italy, 27-31 May 1996; Miraglia, M., van Egmond, H., Brera, C., Gilbert, J., Eds., Alaken Inc.: Fort Collins, CO, USA; pp. 165-179.
87. Cha, S.H., Sekine, T., Kusushura, H., Yu, E., Kim, J.Y., Kim, D.K., Sugiyama, Y., Kanai, Y., Endou, H. Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J. Biol. Chem. 2000, 275, 4507-4512. [CrossRef] [PubMed]
88. Heussner, A.H., Bingle, L.E. Comparative Ochratoxin toxicity: A review of the available data. Toxins 2015, 7, 4253-4282. [CrossRef] [PubMed]
89. Pitout, M.J. The hydrolysis of Ochratoxin A by some proteolytic enzymes. Biochem. Pharmacol. 1969, 18, 485-491. [CrossRef]
90. Doster, R.C., Sinnhuber, R.O. Comparative rate of hydrolysis of Ochratoxin A and B in vitro. Food Cosmet. Toxicol. 1972, 10, 389-394. [CrossRef]
91. Hoehler, D., Sudekum, K.H., Wolfram, S., Frohlich, A.A., Marquardt, R.R. Metabolism and excretion of Ochratoxin A fed to sheep. J. Anim. Sci. 1999, 77, 1217-1223.
92. Madhyastha, M.S., Marquardt, R.R., Frohlich, A.A. Hydrolysis of Ochratoxin A by the microbial activity of digesta in the gastrointestinal tract. Arch. Environ. Contam. Toxicol. 1992, 23, 468-472. [CrossRef] [PubMed]
93. Xiao, H., Madhyastha, S., Marquardt, R.R., Li, S., Vodela, J.K., Frohlich, A.A., Kemppainen, W. Toxicity of OTA, its opened lactone form and several of its analogs: Structure-activity relationships. Toxicol. Appl. Pharmacol. 1996, 137, 182-192. [CrossRef] [PubMed]
94. Stormer, F.C., Pederson, J.I. Formation of (4R)- and (4S)-hydroxyochratoxin A from Ochratoxin A by rat liver microsomes. Appl. Environ. Microbiol. 1980, 39, 971-975. [PubMed]
95. Stormer, F.C., Storen, O., Hansen, C.E., Pedersen, J.I., Hvistendahl, G., Aarsen, A.J. Formation of (4R)- and (4S)-hydroxyochratoxin A from Ochratoxin A by liver microsomes from various species. Appl. Environ. Microbiol. 1981, 42, 1051-1056. [PubMed]
96. Oster, T., Jayyosi, Z., Creppy, E.E., El Amri, H.S., Batt, A.M. Characterization of pig liver purified cytochrome P-450 isoenzymes for Ochratoxin A metabolism studies. Toxicol. Lett. 1991, 57, 203-214. [CrossRef]
97. Hutchinson, R.D., Steyn, P.S., Thompson, D.L. The isolation and structure of 4-hydroxyochratoxin A and 7-carboxy-3,4-dihydro-8-hydroxy-3-methylisocoumarin from Penicillium viridicatum. Tetrahedron Lett. 1971, 43, 4033-4036. [CrossRef]
98. Creppy, E.E., Kern, D., Steyn, P.S., Vleggaar, R., Roschenthaler, R., Dirheimer, G. Comparative study on the effect of Ochratoxin A analogues on yeast aminoacyl-t-RNA synthetases and on the growth and protein synthesis of hepatoma cells. Toxicol. Lett. 1983, 19, 217-224. [CrossRef]
99. Xiao, H., Marquardt, R.R., Abramson, R.R., Frohlich, A.A. Metabolites of ochratoxins in rat urine and in a culture of Aspergillus ochraceus. Appl. Environ. Microbiol. 1996, 62, 648-655. [PubMed]
100. Zepnik, H., Pahler, A., Schauer, U., Dekant, W. Ochratoxin A-Induced tumor formation: Is there a role of reactive Ochratoxin A metabolites? Toxicol. Sci. 2001, 59, 59-67. [CrossRef] [PubMed]
101. Pinelli, E., El Adlouni, C., Pipy, B., Quartulli, F., Pfohl-Leskzowicz, A. Roles of cyclooxygenase and lipoygenases in Ochratoxin A genotoxicity in human epithelial lung cells. Environ. Toxicol. Pharmacol. 1999, 7, 95-107. [CrossRef]
102. El Adlouni, C., Pinelli, E., Azemar, B., Zaoui, D., Beaune, P., Leszkowicz, A.P. Phenobarbital increases of DNA adduct and metabolites formed by Ochratoxin A: Role of CYP 2C9 and microsomal glutathione-S-transferase. Environ. Mol. Mutagen. 2000, 35, 123-131. [CrossRef]
103. Yang, S., Zhang, H., de Saeger, S., de Boevre, M., Sun, F., Zhang, S., Cao, X., Wang, Z. In vitro and in vivo metabolism of Ochratoxin A: A comparative study using ultra-performance liquid chromatography-quadrupole/time-of-flight hybrid mass spectrometry. Anal. Bioanal. Chem. 2015, 407, 3579-3589. [CrossRef] [PubMed]
104. Ueno, Y. Biotransformation of mycotoxins in the reconstituted cytochrome P-450 system. Proc. Jpn. Assoc. Mycotoxicol. 1985, 22, 28-30. [CrossRef]
105. Stormer, F.C., Storen, O., Hansen, C.E., Pedersen, J.I., Aasen, A.J. Formation of (4R)- and (4S)-4-hydroxyochratoxin A and 10-hydroxyochratoxin A from Ochratoxin A by rabbit liver microsomes. Appl. Environ. Microbiol. 1983, 45, 1183-1187. [PubMed]
106. Fink-Gremmels, J., Jahn, A., Blom, M.J. Toxicity and metabolism of Ochratoxin A. Nat. Toxins 1995, 3, 214-220. [CrossRef]
107. Simarro Doorten, A.Y., Bull, S., van der Doelen, M.A., Fink-Gremmels, J. Metabolism-mediated cytotoxicity of Ochratoxin A. Toxicol. In Vitro 2004, 18, 271-277. [CrossRef] [PubMed]
108. Omar, R.F., Gelboin, H.V., Rahimtula, A.D. Effect of cytochrome P450 induction on the metabolism and toxicity of Ochratoxin A. Biochem. Pharmacol. 1996, 51, 207-216. [CrossRef]
109. Grosse, Y., Monje, M.C., Mace, K., Pfeifer, A., Pfohl-Leszkowicz, A. Use of bronchial epithelial cells expressing human cytochrome P450 for study on metabolism and genotoxicity of Ochratoxin A. In Vitro Toxicol. 1997, 10, 93-102.
110. Chu, F.S., Noh, I., Chang, C.C. Structure requirements for Ochratoxin A intoxication. Life Sci. 1972, 11, 503-508.
111. Grosse, Y., Baudrimont, I., Castegnaro, M., Creppy, E.E., Dirheimer, G., Pfohl-Leskowicz, A. Ochratoxin A metabolites and DNA-adducts formation in monkey kidney cell. Chem. Biol. Interact. 1995, 95, 175-187. [CrossRef]
112. Kasmuller, S., Cavin, C., Chakraborty, A., Darroudi, F., Majer, B.J., Huber, W. W., Ehrlich, V.A. Structurally related mycotoxins Ochratoxin A, Ochratoxin B, and citrinin differ in their genotoxic activities and in their mode of action in human-derived liver (HepG2) cells: Implication for Risk Assessment. Nutr. Cancer 2004, 50, 190-197. [CrossRef] [PubMed]
113. Faucet-Marquis, V., Pont, F., Størmer, F.C., Rizk, T., Castegnaro, M., Pfohl-Leszkowicz, A. Evidence of a new dechlorinated Ochratoxin A derivative formed in opossum kidney cell cultures after pretreatment by modulators of glutathione pathways: Correlation with DNA-adduct formation. Mol. Nutr. Food Res. 2006, 50, 530-542. [CrossRef] [PubMed]
114. Gross-Steinmeyer, K.; Weymann, J., Hege, H.G., Metzler, M. Metabolism and lack of DNA reactivity of the mycotoxin Ochratoxin A in cultured and human primary hepatocytes. J. Agric. Food Chem. 2002, 50, 935-938. [CrossRef]
115. Zepnik, H., Volkel, W., Dekant, W. Toxicokinetics of the mycotoxin Ochratoxin A in F 344 rats after oral administration. Toxicol. Appl. Pharmacol. 2003, 192, 36-44. [CrossRef]
116. Malaveille, C., Brun, G., Bartsch, H. Structure-activity studies in E. coli strains on Ochratoxin A (OTA) and its analogues implicate a genotoxic free radical and a cytosolic thiol derivative as reactive metabolites. Mutat. Res. 1994, 307, 141-147. [CrossRef]
117. Dai, J., Park, G.; Wright, M.W., Adams, M., Akman, S.A., Manderville, R.A. Detection and characterization of a glutathione conjugate of Ochratoxin A. Chem. Res. Toxicol. 2002, 15, 1581-1588. [CrossRef] [PubMed]
118. Tozlovanu, M., Canadas, D., Pfohl-Leszkowicz, A., Frenette, C., Paugh, R.J., Manderville, R.A. Glutathione conjugates of Ochratoxin A as biomarkers of exposure. Arh. Hig. Rada Toksikol. 2012, 63, 417-427. [CrossRef] [PubMed]
119. Pfohl-Leszkowicz, A., Pinelli, E., Bartsch, H., Mohr, U., Castegnaro, M. Sex and strain differences in Ochratoxin A metabolism and DNA adduction in two strains of rats. Mol. Carcinog. 1998, 23, 76-83. [CrossRef]
120. Petkova-Bocharova, T., El Adlouni, C., Faucet, V., Pfohl-Leszkowicz, A., Mantle, P. Analysis for DNA adducts, Ochratoxin A content and enzymes expression in kidneys of pigs exposed to mild experimental chronic ochratoxicosis. Facta Univ. Ser. Med. Biol. 2003, 10, 111-115.
121. Pfohl-Leszkowicz, A., Tozlovanu, M., Manderville, R., Peraica, M., Castegnaro, M., Stefanovic, V. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol. Nutr. Food Res. 2007, 51, 1131-1146. [CrossRef] [PubMed]
122. Gekle, M., Silbernagl, S. The role of the proximal tubule in Ochratoxin A nephrotoxicity in vivo. Toxicodynamics and toxicokinetics aspects. Ren. Physiol. Biochem. 1994, 17, 40-49. [PubMed]
123. Groves, C.E., Morales, M., Wright, S.H. Peritubular transport of Ochratoxin A in rabbit renal proximal tubules. J. Pharmacol. Exp. Ther. 1998, 284, 943-948. [PubMed]
124. Kusushura, H., Sekine, T., Utsunomiya-Tate, N.M., Tsuda, M., Kojima, R., Cha, S.H., Sugiyama, Y., Kanai, Y., Endou, H. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J. Biol. Chem. 1999, 274, 13675-13680. [CrossRef]
125. Bahnemann, E., Kerling, H.P., Ensminger, S., Scwerdt, G., Silbernagl, S., Gekle, M. Renal transepithelial secretion of Ochratoxin A in the non-filtering toad kidney. Toxicology 1997, 120, 11-17. [CrossRef]
126. Leier, I., Hummel-Eisenbeiss, J., Cui, Y., Keppler, D. ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. Kidney Int. 2000, 57, 1636-1642. [CrossRef] [PubMed]
127. Dahlman, A., Dantzker, W.H., Silbernagl, S., Gekle, M. Detailed mapping of Ochratoxin A reabsorption along the rate nephron in vivo: The nephrotoxin can be reabsorbed in all nephron segments by different mechanisms. J. Pharmacol. Exp. Ther. 1998, 286, 157-162.
128. Sreemannarayana, O., Frohlich, A.A., Vitti, T.G., Marquardt, R.R., Abramson, D., Phillips, G.D. Studies of the tolerance and disposition of Ochratoxin A in young calves. J. Anim. Sci. 1988, 66, 1703-1711. [PubMed]
129. Suzuki, S., Satoh, T., Yamakazi, M. The pharmacokinetics of Ochratoxin A in rats. Jpn. J. Pharmacol. 1977, 27, 735-744. [CrossRef] [PubMed]
130. Nip, W.K., Chu, F.S. The fate of Ochratoxin A in goats. J. Environ. Sci. Health B 1979, 14, 319-333. [CrossRef] [PubMed]
131. Xiao, H., Marquardt, R.R., Frohlich, A.A., Philips, G.D., Vitti, T.G. Effect of hay and a grain diet on the rate of hydrolysis of Ochratoxin A in the rumen sheep. J. Anim. Sci. 1991, 69, 3706-3714. [PubMed]
132. Fuchs, R., Radic, B., Peraica, M., Hult, K., Plestina, R. Enterohepatic circulation of Ochratoxin A in rats. Period. Biol. 1988, 90, 39-42.
133. Gareis, M., Martlbauer, E., Bauer, J., Gedek, B. Determination of Ochratoxin A in breast milk. Zeitschr. Lebensm. Undersch. Forsch. 1988, 186, 114-117. [CrossRef]
134. Micco, C., Miraglia, M., Brera, C., Corneli, S., Ambruzi, A. Evaluation of Ochratoxin A level in human milk in Italy. Food Addit. Contam. 1995, 12, 351-354. [CrossRef] [PubMed]
135. Skaug, M.A., Helland, I., Solvoll, K., Saugstad, O.D. Presence of Ochratoxin A in human milk in relation to dietary intake. Food Addit. Contam. 2001, 18, 321-327. [CrossRef] [PubMed]
136. Muñoz, K., Blaszkewicz, M., Campos, V., Vega, M., Degen, G.H. Exposure of infants to Ochratoxin A with breast milk. Arch. Toxicol. 2014, 88, 837-846. [CrossRef] [PubMed]
137. Creppy, E.E., Röschenthaler, R., Dirheimer, G. Inhibition of protein synthesis in mice by Ochratoxin A and its prevention by phenylalanine. Food Chem. Toxicol. 1984, 22, 883-886. [CrossRef]
138. Dirheimer, G., Creppy, E.E. Mechanism of action of Ochratoxin A. IARC Sci. Publ. 1991, 115, 171-186. [PubMed]
139. Bruinink, A., Rasony, T., Sidler, C. Reduction of Ochratoxin A toxicity by heat-induced epimerization. In vitro effects of ochratoxins on embryonic chick meningeal and other cell cultures. Toxicology 1997, 118, 205-210. [CrossRef]
140. Bruinink, A., Sidler, C. The neurotoxic effect of Ochratoxin A are reduced by protein binding but not affected byl-phenylalanine. Toxicol. Appl. Pharmacol. 1997, 146, 173-179. [CrossRef] [PubMed]
141. McMaster, D.R., Vedani, A. Ochratoxin A binding to phenlylalanine-tRNA synthetatse: Computational approach to the mechanism of ochratoxicoses and its antagonism. J. Med. Chem. 1999, 42, 3075-3086. [CrossRef] [PubMed]
142. Creppy, E.E., Chakor, K., Fisher, M., Dirheimer, G. The mycotoxin Ochratoxin A is a substrate for phenylalanine hydroxylase in isolated rat hepatocytes and in vivo. Arch. Toxicol. 1990, 64, 279-284. [CrossRef] [PubMed]
143. Vettorazzi, A., van Delft, J., de Cerain, A.L. A review on Ochratoxin A transcriptomic studies. Food Chem. Toxicol. 2013, 59, 766-783. [CrossRef] [PubMed]
144. Poór, M., Veres, B., Jakus, P.B., Antus, C., Montskó, G., Zrínyi, Z., Vladimir-Knežević, S., Petrik, J., Kőszegi, T. Flavonoid diosmetin increases ATP levels in kidney cells and relieves ATP depleting effect of Ochratoxin A. J. Photochem. Photobiol. B 2014, 132, 1-9. [CrossRef] [PubMed]
145. Aleo, M.D., Wyat, R.D., Schnellmann, R.G. Mitochondrial dysfunction is an early event in Ochratoxin A but not oosporein toxicity to rat renal proximal tubules. Toxicol. Appl. Pharmacol. 1991, 107, 73-80. [CrossRef]
146. Meisner, H., Meisner, P. Ochratoxin A an in vivo inhibitor of renal phosphoenolpyruvate carboxykinase. Arch. Biochem. Biophys. 1981, 208, 146-153. [CrossRef]
147. Meisner, H., Krogh, P. Phosphoenolpyruvate carboxykinase as a selective indicator of Ochratoxin A induced nephropathy. Dev. Toxicol. Environ. Sci. 1986, 14, 199-206. [PubMed]
148. Meisner, H., Polsinelli, P. Changes of renal mRNA species abundance by Ochratoxin A. Biochem. Pharmacol. 1986, 35, 661-665. [CrossRef]
149. Thekkumkarra, T.J., Patel, M.S. Ochratoxin A decrease the activity of phosphoenolpyruvate carboxykinase and its mRNA content in primary cultures of rat kidney proximal convoluted tubular cells. Biochem. Biophys. Res. Commun. 1989, 162, 916-920. [CrossRef]
150. Suzuki, S., Kozuka, Y., Satoh, T., Yamazaki, M. Studies on the nephrotoxicity of Ochratoxin A in rats. Toxicol. Appl. Pharmacol. 1975, 34, 479-490. [CrossRef]
151. Meisner, H., Chan, S. Ochratoxin A, an inhibitor of mitochondrial transport systems. Biochemistry 1974, 13, 2795-2800. [CrossRef] [PubMed]
152. Wei, Y.H., Lu, T.N., Wei, R.D. Effect of Ochratoxin A on rat liver mitochondrial respiration and oxidative phosphorilation. Toxicology 1985, 36, 119-123. [CrossRef]
153. Manderville, R.A., Pfohl-Leszkowicz, A. Genotoxicity of chlorophenols and Ochratoxin A. Adv. Mol. Toxicol. 2006, 1, 73-118.
154. Waidyanatha, S., Lin, P.H., Rappaport, S.M. Characterization of chlorinated adducts of hemoglobin and albumin following administration of pentachlorophenol to rats. Chem. Res. Toxicol. 1996, 9, 647-653. [CrossRef] [PubMed]
155. Vaidyanathan, V.G., Villalta, P.W., Sturla, S.J. Nucleobase-dependent reactivity of a quinone metabolite of pentachlorophenol. Chem. Res. Toxicol. 2007, 20, 913-919. [CrossRef] [PubMed]
156. Tozlovanu, M., Faucet-Marquis, V., Pfohl-Leszkowicz, A., Manderville, R.A. Genotoxicity of the hydroquinone metabolite of Ochratoxin A: Structure-activity relationships for covalent DNA adduction. Chem. Res. Toxicol. 2006, 19, 1241-1247. [CrossRef] [PubMed]
157. Gillman, I.G., Clark, T.N., Manderville, R.A. Oxidation of Ochratoxin A by an Fe-porphyrin system: Model for enzymatic activation and DNA cleavage. Chem. Res. Toxicol. 1999, 12, 1066-1076. [CrossRef] [PubMed]
158. Reljic, Z., Zlatovic, M., Savic-Radojevic, A., Pekmezovic, T., Djukanovic, L., Matic, M., Pljesa-Ercegovac, M., Mimic-Oka, J., Opsenica, D., Simic, T. Is increased susceptibility to Balkan endemic nephropathy in carriers of common GSTA1 (*A/*B) polymorphism linked with the catalytic role of GSTA1 in Ochratoxin A biotransformation? Serbian case control study and in silico analysis. Toxins 2014, 6, 2348-2362. [CrossRef] [PubMed]
159. Mally, A., Zepnik, H., Wanek, P., Eder, E., Dingley, K., Ihmels, H., Völkel, W., Dekant, W. Ochratoxin A: Lack of formation of covalent DNA adducts. Chem. Res. Toxicol. 2004, 17, 234-242. [CrossRef] [PubMed]
160. Samokyszyn, V.M., Freeman, J.P., Maddipati, K.R., Lloyd, R.V. Peroxidase-catalyzed oxidation of pentachlorophenol. Chem. Res. Toxicol. 1995, 8, 349-355. [CrossRef] [PubMed]
161. El Adlouni, C., Pinelli, E., Azémar, B., Zaoui, D., Beaune, P., Pfohl-Leszkowicz, A. Role of CYP 2C and microsomal glutathione-S-transferase in modulating susceptibility to Ochratoxin A genotoxicity. Environ. Mol. Mutagen. 2000, 35, 123-131. [CrossRef]
162. Stoyanovosky, D.A., Goldman, R., Jonnalagadda, S.S., Day, B.W., Claycamp, H.G., Kagan, V.E. Detection and characterization of the electron paramagnetic resonance-silent glutathionyl-5,5-dimethyl-1-pyrroline N-oxide adduct derived from redox cycling of phenoxyl radicals in model systems and HL-60 cells. Arch. Biochem. Biophys. 1996, 330, 3-11. [CrossRef] [PubMed]
163. Murray, A.R., Kisin, E., Castranova, V., Kommineni, C., Gunther, M.R., Shvedova, A.A. Phenol-induced in vivo oxidative stress in skin: Evidence for enhanced free radical generation, thiol oxidation, and antioxidant depletion. Chem. Res. Toxicol. 2007, 20, 1769-1777. [CrossRef] [PubMed]
164. Kamp, H.G., Eisenbrand, G., Schlatter, J., Würth, K., Janzowski, C. Ochratoxin A: Induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 2005, 206, 413-425. [CrossRef] [PubMed]
165. Dai, J., Wright, M.W., Manderville, R.A. An oxygen-bonded C8-deoxyguanosine nucleoside adduct of pentachlorophenol by peroxidase activation: Evidence for ambident C8 reactivity by phenoxyl radicals. Chem. Res. Toxicol. 2003, 16, 817-821. [CrossRef] [PubMed]
166. Dai, J., Sloat, A.L., Wright, M.W., Manderville, R.A. Role of phenoxyl radicals in DNA adduction by chlorophenol xenobiotics following peroxidase activation. Chem. Res. Toxicol. 2005, 18, 771-779. [CrossRef] [PubMed]
167. Mohn, W.W., Kennedy, K.J. Reductive dehalogenation of chlorophenols by Desulfomonile tiedjei DCB-1. Appl. Environ. Microbiol. 1992, 58, 1367-1370. [PubMed]
168. Lawson, T., Gannett, P.M., Yau, W.M., Dalal, N.S., Toth, B. Different patterns of mutagenicity of arenediazonium ions in V79 cells and Salmonella typhimurium TA102: Evidence for different mechanisms of action. J. Agric. Food Chem. 1995, 43, 2627-2635. [CrossRef]
169. Hiramoto, K., Kaku, M., Sueyoshi, A., Fujise, M., Kikugawa, K. DNA base and deoxyribose modification by the carbon-centered radical generated from 4-(hydroxymethyl)-benzenediazonium salt, a carcinogen in mushroom. Chem. Res. Toxicol. 1995, 8, 356-362. [CrossRef] [PubMed]
170. Gannett, P.M., Powell, J.H., Rao, R., Shi, X., Lawson, T., Kolar, C., Toth, B. C8-Arylguanine and C8-aryladenine formation in calf thymus DNA from arenediazonium ions. Chem. Res. Toxicol. 1999, 12, 297-304. [CrossRef] [PubMed]
171. Dai, J., Wright, M.W., Manderville, R.A. Ochratoxin a forms a carbon-bonded C8-deoxyguanosine nucleoside adduct: Implications for C8 reactivity by a phenolic radical. J. Am. Chem. Soc. 2003, 125, 3716-3717. [CrossRef] [PubMed]
172. Il'ichev, Y.V., Perry, J.L., Manderville, R.A., Chignell, C.F., Simon, J.D. The pH-dependent primary photoreactions of Ochratoxin A. J. Phys. Chem. B 2001, 105, 11369-11376. [CrossRef]
173. Faucet, V., Pfohl-Leszkowicz, A., Dai, J., Castegnaro, M., Manderville, R.A. Evidence for covalent DNA adduction by Ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem. Res. Toxicol. 2004, 17, 1289-1296. [CrossRef] [PubMed]
174. Pfohl-Leszkowicz, A., Gabryelski, W., Manderville, R.A. Formation of 21-deoxyguanosine-carbon 8-bound Ochratoxin A adduct in rat kidney DNA. Mol. Nutr. Food Res. 2009, 53, 154-155. [CrossRef] [PubMed]
175. Pfohl-Leszkowicz, A., Castegnaro, M. Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation. Food Addit. Contam. 2005, 22 (Suppl. 1), 75-87. [CrossRef] [PubMed]
176. Mantle, P.G., Faucet-Marquis, V., Manderville, R.A., Squillaci, B., Pfohl-Leszkowicz, A. Structures of covalent adducts between DNA and Ochratoxin A: A new factor in debate about genotoxicity and human risk assessment. Chem. Res. Toxicol. 2010, 23, 89-98. [CrossRef] [PubMed]
177. Mally, A., Pepe, G., Ravoori, S., Fiore, M., Gupta, R.C., Dekant, W., Mosesso, P. Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem. Res. Toxicol. 2005, 18, 1253-1261. [CrossRef] [PubMed]
178. Delatour, T., Mally, A., Richoz, J., Ozden, S., Dekant, W., Ihmels, H., Otto, D., Gasparutto, D., Marin-Kuan, M., Schilter, B., et al. Absence of 21-deoxyguanosine-carbon 8-bound Ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS. Mol. Nutr. Food Res. 2008, 52, 472-482. [CrossRef] [PubMed]
179. Mally, A. Ochratoxin A and mitotic disruption: Mode of action analysis of renal tumor formation by Ochratoxin A. Toxicol. Sci. 2012, 127, 315-330. [CrossRef] [PubMed]
180. Stiborová, M., Bárta, F., Levová, K., Hodek, P., Frei, E., Arlt, V.M., Schmeiser, H.H. The influence of Ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats. Arch. Toxicol. 2015, 89, 2141-2158. [CrossRef] [PubMed]
181. Sorrenti, V., di Giacomo, C., Acquaviva, R., Barbagallo, I., Bognanno, M., Galvano, F. Toxicity of Ochratoxin A and its modulation by antioxidants: A review. Toxins 2013, 5, 1742-1766. [CrossRef] [PubMed]
182. Rahimtula, A.D., Béréziat, J.C., Bussacchini-Griot, V., Bartsch, H. Lipid peroxidation as a possible cause of Ochratoxin A toxicity. Biochem. Pharmacol. 1988, 37, 4469-4477. [CrossRef]
183. Omar, R.F., Hasinoff, B.B., Mejilla, F., Rahimtula, A.D. Mechanism of Ochratoxin A stimulated lipid peroxidation. Biochem. Pharmacol. 1990, 40, 1183-1191. [CrossRef]
184. Ranaldi, G., Caprini, V., Sambuy, Y., Perozzi, G., Murgia, C. Intracellular zinc stores protect the intestinal epithelium from Ochratoxin A toxicity. Toxicol. In Vitro 2009, 23, 1516-1521. [CrossRef] [PubMed]
185. Zheng, J., Zhang, Y., Xu, W., Luo, Y., Hao, J., Shen, X.L., Yang, X., Li, X., Huang, K. Zinc protects HepG2 cells against the oxidative damage and DNA damage induced by Ochratoxin A. Toxicol. Appl. Pharmacol. 2013, 268, 123-131. [CrossRef] [PubMed]
186. Poór, M., Kuzma, M., Matisz, G., Li, Y., Perjési, P., Kunsági-Máté, S., Kőszegi, T. Further aspects of Ochratoxin A-cation interactions: Complex formation with zinc ions and a novel analytical application of Ochratoxin A-magnesium interaction in the HPLC-FLD system. Toxins 2014, 6, 1295-1307. [CrossRef] [PubMed]
187. Marin-Kuan, M., Nestler, S., Verguet, C., Bezençon, C., Piguet, D., Mansourian, R., Holzwarth, J., Grigorov, M., Delatour, T., Mantle, P., et al. A toxicogenomics approach to identify new plausible epigenetic mechanisms of Ochratoxin A carcinogenicity in rat. Toxicol. Sci. 2006, 89, 120-134. [CrossRef] [PubMed]
188. Cavin, C., Delatour, T., Marin-Kuan, M., Holzhäuser, D., Higgins, L., Bezençon, C., Guignard, G., Junod, S., Richoz-Payot, J., Gremaud, E., et al. Reduction in antioxidant defenses may contribute to Ochratoxin A toxicity and carcinogenicity. Toxicol. Sci. 2007, 96, 30-39. [CrossRef] [PubMed]
189. Boesch-Saadatmandi, C., Loboda, A., Jozkowicz, A., Huebbe, P., Blank, R., Wolffram, S., Dulak, J., Rimbach, G. Effect of Ochratoxin A on redox-regulated transcription factors, antioxidant enzymes and glutathione-S-transferase in cultured kidney tubulus cells. Food Chem. Toxicol. 2008, 46, 2665-2671. [CrossRef] [PubMed]
190. Limonciel, A., Jennings, P. A review of the evidence that Ochratoxin A is an Nrf2 inhibitor: Implications for nephrotoxicity and renal carcinogenicity. Toxins 2014, 6, 371-379. [CrossRef] [PubMed]
191. Cavin, C., Delatour, T., Marin-Kuan, M., Fenaille, F., Holzhäuser, D., Guignard, G., Bezençon, C., Piguet, D., Parisod, V., Richoz-Payot, J., et al. Ochratoxin A-mediated DNA and protein damage: Roles of nitrosative and oxidative stresses. Toxicol. Sci. 2009, 110, 84-94. [CrossRef] [PubMed]
192. Qi, X., Yu, T., Zhu, L., Gao, J., He, X., Huang, K., Luo, Y., Xu, W. Ochratoxin A induces rat renal carcinogenicity with limited induction of oxidative stress responses. Toxicol. Appl. Pharmacol. 2014, 280, 543-549. [CrossRef] [PubMed]
193. Taniai, E., Yafune, A., Nakajima, M., Hayashi, S.M., Nakane, F., Itahashi, M., Shibutani, M. Ochratoxin A induces karyomegaly and cell cycle aberrations in renal tubular cells without relation to induction of oxidative stress responses in rats. Toxicol. Lett. 2014, 224, 64-72. [CrossRef] [PubMed]
194. Gekle, M., Schwerdt, G., Freudinger, R., Mildenberg, S., Wilflingseder, D., Pollack, V., Dander, M., Schramek, H. Ochratoxin A induces JNK activation and apoptosis in MDKC-C7 cells at nanomolar concentrations. J. Pharmacol. Exp. Ther. 2000, 293, 837-844. [PubMed]
195. Lühe, A., Hildebrandt, H., Bach, U., Dingerman, T., Ahr, H.J. A new approach to studying Ochratoxin A (OTA)-induced nephrotoxicity: Expressing profiling in vivo and in vitro employing cDNA microarrays. Toxicol. Sci. 2003, 73, 315-328. [CrossRef] [PubMed]
196. Kuroda, K., Hibi, D., Ishii, Y., Yokoo, Y., Takasu, S., Kijima, A., Matsushita, K., Masumura, K., Kodama, Y., Yanai, T., et al. Role of p53 in the progression from ochratoxin A-induced DNA damage to gene mutations in the kidneys of mice. Toxicol. Sci. 2015, 144, 65-76. [CrossRef] [PubMed]
197. Horvath, A., Upham, B.L., Ganev, V., Trosko, J.E. Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line. Toxicon 2002, 40, 273-282. [CrossRef]
198. Sauvant, C., Holzinger, H., Gekle, M. The nephrotoxin Ochratoxin A induces key parameters of chronic interstitial nephropathy in renal proximal tubular cells. Cell Physiol. Biochem. 2005, 15, 125-134. [CrossRef] [PubMed]
199. Özcan, Z., Gül, G., Yaman, I. Ochratoxin A activates opposing c-MET/PI3K/Akt and MAPK/ERK 1-2 pathways in human proximal tubule HK-2 cells. Arch. Toxicol. 2015, 89, 1313-1327. [CrossRef] [PubMed]
200. Liang, R., Shen, X.L., Zhang, B., Li, Y., Xu, W., Zhao, C., Luo, Y., Huang, K. Apoptosis signal-regulating kinase 1 promotes Ochratoxin A-induced renal cytotoxicity. Sci. Rep. 2015, 5, 8078. [CrossRef] [PubMed]
201. Atroshi, F., Biese, I., Saloniemi, H. Significance of apoptosis and its relationship to antioxidants after Ochratoxin A administration in mice. J. Pharm. Pharm. Sci. 2000, 3, 281-291. [PubMed]
202. Petrik, J., Zanic-Grubisic, T., Barisic, K., Pepeljnjak, S., Radic, B., Ferencic, Z., Cepelak, I. Apoptosis and oxidative stress induced by Ochratoxin A in rat kidney. Arch. Toxicol. 2003, 77, 685-693. [CrossRef] [PubMed]
203. Weidenbach, A., Schuh, K., Failing, K., Petzinger, E. Ochratoxin A induced TNF-release from the isolated and blood-free perfused rat liver. Mycotoxin Res. 2000, 16, 189-193. [CrossRef] [PubMed]
204. Al-Anati, L., Katz, N., Petzinger, E. Interference of arachidonic acid and its metabolites with TNFα release by Ochratoxin A from rat liver. Toxicology 2005, 208, 335-346. [CrossRef] [PubMed]
205. Petzinger, E., Weidenbach, A. Mycotoxins in the food chain: The role of ochratoxins. Livest. Prod. Sci. 2002, 76, 245-250. [CrossRef]
206. Rached, E., Pfeiffer, E., Dekant, W., Mally, A. Ochratoxin A: Apoptosis and aberrant exit from mitosis due to perturbation of microtubule dynamics? Toxicol. Sci. 2006, 92, 78-86. [CrossRef] [PubMed]
207. Mally, A., Dekant, W. Mycotoxins and the kidney: Modes of action for renal tumor formation by Ochratoxin A in rodents. Mol. Nutr. Food Res. 2009, 53, 467-478. [CrossRef] [PubMed]
208. Adler, M., Müller, K., Rached, E., Dekant, W., Mally, A. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in Ochratoxin A carcinogenicity. Carcinogenesis 2009, 30, 711-719. [CrossRef] [PubMed]
209. Czakai, K., Müller, K., Mosesso, P., Pepe, G., Schulze, M., Gohla, A., Patnaik, D., Dekant, W., Higgins, J.M.G., Mally, A. Perturbation of mitosis through inhibition of histone acetyltransferases: The key to Ochratoxin A toxicity and carcinogenicity? Toxicol. Sci. 2011, 122, 317-329. [CrossRef] [PubMed]
210. O'Brien, E., Heussner, A.H., Dietrich, D.R. Species-, sex-, and cell type-specific effects of Ochratoxin A and B. Toxicol. Sci. 2001, 63, 256-264. [CrossRef] [PubMed]
211. Palma, N., Cinelli, S., Sapora, O., Wilson, S.H., Dogliotti, E. Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress. Chem. Res. Toxicol. 2007, 20, 1031-1037. [CrossRef] [PubMed]
212. Wang, Y., Liu, J., Cui, J., Xing, L., Wang, J., Yan, X., Zhang, X. ERK and p38 MAPK signaling pathways are involved in Ochratoxin A-induced G2 phase arrest in human gastric epithelium cells. Toxicol. Lett. 2012, 209, 186-192. [CrossRef] [PubMed]
213. Cui, J., Liu, J., Wu, S., Wang, Y., Shen, H., Xing, L., Wang, J., Yan, X., Zhang, X. Oxidative DNA damage is involved in Ochratoxin A-induced G2 arrest through ataxia telangiectasia-mutated (ATM) pathways in human gastric epithelium GES-1 cells in vitro. Arch. Toxicol. 2013, 87, 1829-1840. [CrossRef] [PubMed]
214. Liu, J., Wang, Y., Cui, J., Xing, L., Shen, H., Wu, S., Lian, H., Wang, J., Yan, X., Zhang, X. Ochratoxin A induces oxidative DNA damage and G1 phase arrest in human peripheral blood mononuclear cells in vitro. Toxicol. Lett. 2012, 211, 164-171. [CrossRef] [PubMed]
215. Yang, Q., He, X., Li, X., Xu, W., Luo, Y., Yang, X., Wang, Y., Li, Y., Huang, K. DNA damage and S phase arrest induced by Ochratoxin A in human embryonic kidney cells (HEK 293). Mutat. Res. 2014, 765, 22-31. [CrossRef] [PubMed]
216. Yang, Q., Shi, L., Huang, K., Xu, W. Protective effect of N-acetylcysteine against DNA damage and S-phase arrest induced by Ochratoxin A in human embryonic kidney cells (HEK-293). Food Chem Toxicol. 2014, 70, 40-47. [CrossRef] [PubMed]
217. Khan, S., Martin, M., Bartsch, H., Rahimtula, A.D. Perturbation of liver microsomal calcium homeostasis by Ochratoxin A. Biochem. Pharmacol. 1989, 38, 67-72. [CrossRef]
218. Dopp, E., Müller, J., Hahnel, C., Schiffmann, D. Induction of genotoxic effects and modulation of the intracellular calcium level in Syrian Hamster Embryo (SHE) fibroblasts caused by Ochratoxin A. Food Chem. Toxicol. 1999, 37, 713-721. [CrossRef]
219. Hoehler, D., Marquardt, R.R., McIntosh, A.R., Xiao, H. Free radical generation as induced by Ochratoxin A and its analogs in bacteria (Bacillus brevis). J. Biol. Chem. 1996, 271, 27388-27394. [CrossRef] [PubMed]
220. Hoehler, D., Marquardt, R.R., McIntosh, A.R., Hatch, G.M. Induction of free radicals in hepatocytes, mitochondria and microsomes of rats by Ochratoxin A and its analogs. Biochim. Biophys. Acta 1997, 1357, 225-233. [CrossRef]
221. Benesic, A., Mildenberger, S., Gekle, M. Nephritogenic Ochratoxin A interferes with hormonal signalling in immortalized human kidney epithelial cells. Pflügers Arch. 2000, 439, 278-287. [CrossRef] [PubMed]
222. García, A.R., Avila, E., Rosiles, R., Petrone, V.M. Evaluation of two mycotoxin binders to reduce toxicity of broiler diets containing Ochratoxin A and T-2 toxin contaminated grain. Avian Dis. 2003, 47, 691-699. [CrossRef] [PubMed]
223. Trailović, J.N., Stefanović, S., Trailović, S.M. In vitro and in vivo protective effects of three mycotoxin adsorbents against Ochratoxin A in broiler chickens. Br. Poult. Sci. 2013, 54, 515-523. [CrossRef] [PubMed]
224. Madhyastha, M.S., Frohlich, A.A., Marquardt, R.R. Effect of dietary cholestyramine on the elimination pattern of Ochratoxin A in rats. Food Chem. Toxicol. 1992, 30, 709-714. [CrossRef]
225. Kerkadi, A., Barriault, C., Marquardt, R.R., Frohlich, A.A., Yousef, I.M., Zhu, X.X., Tuchweber, B. Cholestyramine protection against Ochratoxin A toxicity: Role of Ochratoxin A sorption by the resin and bile acid enterohepatic circulation. J. Food Prot. 1999, 62, 1461-1465. [PubMed]
226. Yong, S., Albassam, M., Prior, M. Protective effects of sodium bicarbonate on murine ochratoxicosis. J. Environ. Sci. Health B 1987, 22, 455-470. [CrossRef] [PubMed]
227. Baudrimont, I., Murn, M., Betbeder, A.M., Guilcher, J., Creppy, E.E. Effect of piroxicam on the nephrotoxicity induced by Ochratoxin A in rats. Toxicology 1995, 95, 147-154. [CrossRef]
228. Moroi, K., Suzuki, S., Kuga, T., Yamazaki, M., Kanisawa, M. Reduction of Ochratoxin A toxicity in mice treated with phenylalanine and phenobarbital. Toxicol. Lett. 1985, 25, 1-5. [PubMed]
229. Chakor, K., Creppy, E.E., Dirheimer, G. In vivo Studies on the relationship between hepatic metabolism and toxicity of Ochratoxin A. Arch. Toxicol. 1988, 12, 201-204.
230. Suzuki, S., Moroi, K., Kanisawa, M., Satoh, T. Effect of drug metabolizing enzyme inducers on carcinogenesis and toxicity of Ochratoxin A in mice. Toxicol. Lett. 1986, 31, 206.
231. Creppy, E.E., Schlegel, M., Röschenthaler, R., Dirheimer, G. Phenylalanine prevents acute poisoning by ochratoxina in mice. Toxicol. Lett. 1980, 6, 77-80. [CrossRef]
232. Baudrimont, I., Betbeder, A.M., Creppy, E.E. Reduction of the Ochratoxin A-induced cytotoxicity in Vero cells by aspartame. Arch. Toxicol. 1997, 71, 290-298. [CrossRef] [PubMed]
233. Baudrimont, I., Sostaric, B., Yenot, C., Betbeder, A.M., Dano-Djedje, S., Sanni, A., Steyn, P.S., Creppy, E.E. Aspartame prevents the karyomegaly induced by Ochratoxin A in rat kidney. Arch. Toxicol. 2001, 75, 176-183. [PubMed]
234. Stoev, S.D. Studies on carcinogenic and toxic effects of Ochratoxin A in chicks. Toxins 2010, 2, 649-664. [CrossRef] [PubMed]
235. Creppy, E.E., Baudrimont, I., Belmadani, A., Betbeder, A.M. Aspartame as a preventive agent of chronic toxic effects of Ochratoxin A in experimental animals. Toxin Rev. 1996, 15, 207-221. [CrossRef]
236. Pfohl-Leszkowicz, A., Bartsch, H., Azémar, B., Mohr, U., Estève, J., Castegnaro, M. MESNA protects rats against nephrotoxicity but not carcinogenicity induced by Ochratoxin A, implicating two separate pathways. Facta Univ. Ser. Med. Biol. 2002, 9, 57-63.
237. Kumari, D., Sinha, S.P. Effect of retinol on ochratoxin-produced genotoxicity in mice. Food Chem. Toxicol. 1994, 32, 471-475. [CrossRef]
238. Hoehler, D., Marquardt, R.R. Influence of vitamins E and C on the toxic effects of Ochratoxin A and T-2 toxin in chicks. Poult. Sci. 1996, 75, 1508-1515. [CrossRef] [PubMed]
239. Grosse, Y., Chekir-Ghedira, L., Huc, A., Obrecht-Pflumio, S., Dirheimer, G., Bacha, H., Pfohl-Leszkowicz, A. Retinol, ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice treated with the mycotoxins Ochratoxin A and zearalenone. Cancer Lett. 1997, 114, 225-229. [CrossRef]
240. Baldi, A., Losio, M.N., Cheli, F., Rebucci, R., Sangalli, L., Fusi, E., Bertasi, B., Pavoni, E., Carli, S., Politis, I. Evaluation of the protective effects of alpha-tocopherol and retinol against Ochratoxin A cytotoxicity. Br. J. Nutr. 2004, 91, 507-512. [CrossRef] [PubMed]
241. Costa, S., Utan, A., Cervellati, R., Speroni, E., Guerra, M.C. Catechins: Natural free-radical scavengers against Ochratoxin A-induced cell damage in a pig kidney cell line (LLC-PK1). Food Chem. Toxicol. 2007, 45, 1910-1917. [CrossRef] [PubMed]
242. Renzulli, C., Galvano, F., Pierdomenico, L., Speroni, E., Guerra, M.C. Effects of rosmarinic acid against aflatoxin B1 and Ochratoxin-A-induced cell damage in a human hepatoma cell line (Hep G2). J. Appl. Toxicol. 2004, 24, 289-296. [CrossRef] [PubMed]
243. Russo, A., la Fauci, L., Acquaviva, R., Campisi, A., Raciti, G., Scifo, C., Renis, M., Galvano, G., Vanella, A., Galvano, F. Ochratoxin A-induced DNA damage in human fibroblast: Protective effect of cyanidin 3-O-beta-D-glucoside. J. Nutr. Biochem. 2005, 16, 31-37. [CrossRef] [PubMed]
244. Guerra, M.C., Galvano, F., Bonsi, L., Speroni, E., Costa, S., Renzulli, C., Cervellati, R. Cyanidin-3-O-beta-glucopyranoside, a natural free-radical scavenger against aflatoxin B1- and Ochratoxin A-induced cell damage in a human hepatoma cell line (Hep G2) and a human colonic adenocarcinoma cell line (CaCo-2). Br. J. Nutr. 2005, 94, 211-220. [CrossRef] [PubMed]
245. Sorrenti, V., di Giacomo, C., Acquaviva, R., Bognanno, M., Grilli, E., D'Orazio, N., Galvano, F. Dimethylarginine dimethylaminohydrolase/nitric oxide synthase pathway in liver and kidney: Protective effect of cyanidin 3-O-β-D-glucoside on Ochratoxin-A toxicity. Toxins 2012, 4, 353-363. [CrossRef] [PubMed]
246. Essid, E., Dernawi, Y., Petzinger, E. Apoptosis induction by OTA and TNF-α in cultured primary rat hepatocytes and prevention by silibinin. Toxins 2012, 4, 1139-1156. [CrossRef] [PubMed]
247. Cariddi, L.N., Sabini, M.C., Escobar, F.M., Montironi, I., Manas, F., Iglesias, D., Comini, L.R., Sabini, L.I., Dalcero, A.M. Polyphenols as possible bioprotectors against cytotoxicity and DNA damage induced by Ochratoxin A. Environ. Toxicol. Pharmacol. 2015, 39, 1008-1018. [CrossRef] [PubMed]
248. Ramyaa, P., Padma, V.V. Ochratoxin-induced toxicity, oxidative stress and apoptosis ameliorated by quercetin—Modulation by Nrf2. Food Chem. Toxicol. 2013, 62, 205-216. [CrossRef] [PubMed]
249. Ramyaa, P., Krishnaswamy, R., Padma, V.V. Quercetin modulates OTA-induced oxidative stress and redox signalling in HepG2 cells—up regulation of Nrf2 expression and down regulation of NF-κB and COX-2. Biochim. Biophys. Acta 2014, 1840, 681-692. [CrossRef] [PubMed]
250. Aydin, S., Palabiyik, S.S., Erkekoglu, P., Sahin, G., Başaran, N., Giray, B.K. The carotenoid lycopene protects rats against DNA damage induced by Ochratoxin A. Toxicon 2013, 73, 96-103. [CrossRef] [PubMed]
251. Palabiyik, S.S., Erkekoglu, P., Zeybek, N.D., Kizilgun, M., Baydar, D.E., Sahin, G., Giray, B.K. Protective effect of lycopene against Ochratoxin A induced renal oxidative stress and apoptosis in rats. Exp. Toxicol. Pathol. 2013, 65, 853-861. [CrossRef] [PubMed]
252. Abdel-Wahhab, M.A., Abdel-Azim, S.H., El-Nekeety, A.A. Inula crithmoides extract protects against Ochratoxin A-induced oxidative stress, clastogenic and mutagenic alterations in male rats. Toxicon 2008, 52, 566-573. [CrossRef] [PubMed]
253. Chakraborty, D., Verma, R. Ameliorative effect of Emblica officinalis aqueous extract on ochratoxin-induced lipid peroxidation in the kidney and liver of mice. Int. J. Occup. Med. Environ. Health 2010, 23, 63-73. [CrossRef] [PubMed]
254. Gan, F., Xue, H., Huang, Y., Pan, C., Huang, K. Selenium alleviates porcine nephrotoxicity of Ochratoxin A by improving selenoenzyme expression in vitro. PLoS ONE 2015, 10, e119808.
255. Mantle, P., Kilic, M.A., Mor, F., Ozmen, O. Contribution of organ vasculature in rat renal analysis for Ochratoxin A: Relevance to toxicology of nephrotoxins. Toxins 2015, 7, 1005-1017. [CrossRef] [PubMed]
256. Obrecht-Pflumio, S., Grosse, Y., Pfohl-Leszkowicz, A., Dirheimer, G. Protection by indomethacin and aspirin against genotoxicity of Ochratoxin A, particularly in the urinary bladder and kidney. Arch. Toxicol. 1996, 70, 244-248. [CrossRef] [PubMed]
257. Baudrimont, I., Ahouandjivo, R., Creppy, E.E. Prevention of lipid peroxidation induced by Ochratoxin A in Vero cells in culture by several agents. Chem. Biol. Interact. 1997, 104, 29-40. [CrossRef]
258. Galtier, P., Camguilhem, R., Bodin, G. Evidence for in vitro and in vivo interaction between Ochratoxin A and three acidic drugs. Food Cosmet. Toxicol. 1980, 18, 493-496. [CrossRef]
259. Creppy, E.E., Baudrimont, I., Betbeder, A.M. Prevention of nephrotoxicity of Ochratoxin A, a food contaminant. Toxicol. Lett. 1995, 82-83, 869-877. [CrossRef]
260. Hong, S.S., Seo, K., Lim, S.C., Han, H.K. Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3). Pharmacol. Res. 2007, 56, 468-473. [CrossRef] [PubMed]
261. Wong, C.C., Botting, N.P., Orfila, C., Al-Maharik, N., Williamson, G. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Biochem. Pharmacol. 2011, 81, 942-949. [CrossRef] [PubMed]
262. Wang, X., Wolkoff, A.W., Morris, M.E. Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab. Dispos. 2005, 33, 1666-1672. [CrossRef] [PubMed]
263. Sergent, T., Garsou, S., Schaut, A., Saeger, S.D., Pussemier, L., Peteghem, C.V., Larondelle, Y., Schneider, Y.J. Differential modulation of Ochratoxin A absorption across Caco-2 cells by dietary polyphenols, used at realistic intestinal concentrations. Toxicol. Lett. 2005, 159, 60-70. [CrossRef] [PubMed]
264. Brand, W., Schutte, M.E., Williamson, G., van Zanden, J.J., Cnubben, N.H.P., Groten, J.P., van Bladeren, P.J., Rietjens, I.M.C.M. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed. Pharmacother. 2006, 60, 508-519. [CrossRef] [PubMed]
265. Havsteen, B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 2002, 96, 67-202. [CrossRef]
266. Dangles, O., Dufour, C., Manach, C., Morand, C., Remesy, C. Binding of flavonoids to plasma proteins. Methods Enzymol. 2001, 335, 319-333. [PubMed]